View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
September 23, 2021

Medtronic evaluates Braive growth modulation system in paediatric trial

The prospective trial will check the system’s safety and effectiveness in correcting the spine's curve.

Medtronic has enrolled the first subject and completed the first surgical procedure in its paediatric clinical trial of the Braive growth modulation system to treat progressive adolescent idiopathic scoliosis (AIS).

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

The BRAIVE IDE trial enrolled the first participant at The Newcastle Upon Tyne Hospitals NHS Foundation Trust in the UK.

Scoliosis is considered one of the most common paediatric orthopaedic deformities and develops due to twisting or rotating of the vertebrae, which causes the spine to curve into a ‘C’ or ‘S’ shape instead of growing in a straight line.

The condition usually develops in children and current standard treatment options are braces or spinal fusion surgery.

As part of Medtronic’s paediatric spine portfolio, Braive uses a braid held to the spine with screws to slow growth on the spine’s curved side while allowing the continuation of growth on the other side.

The prospective, multi-centre BRAIVE IDE trial will assess the safety and effectiveness of the growth modulation system in correcting the curve of the spine in juvenile or AIS patients.

In addition to the UK, participants for the trial will be recruited across the US and Canada.

Medtronic spine and biologics vice-president and general manager Carlton Weatherby said: “As image guidance and navigation compatibilities extend further into additional spinal implant systems indicated for paediatric populations, they are coupled with a rapid cadence of transformative implant innovation.

“This uniquely positions us to offer the most comprehensive and integrated ecosystem of procedural solutions to paediatric spine surgeons driving meaningful improvements in clinical outcomes for young patients.”

BRAIVE IDE is designed to enrol 25 subjects, with a change in pre-operative Cobb angle versus the Cobb angle at 24 months after surgery being the primary outcome.

Another primary outcome measure in the trial is the number of secondary spinal surgeries determined as treatment failure up to 24 months after the Braive surgery.

Last month, Medtronic signed a definitive agreement to acquire ear, nose and throat medical technology company Intersect ENT.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network